PODD vs PUBM · P/E 34, rev $2.07B vs P/E 156, rev $282.9M
Insulet Corporation (PODD) versus Pubmatic Inc (PUBM) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Pubmatic Inc (PUBM) is a software - application company listed on US.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported PUBM revenue for 2025-12-31 was $282.9M. Net income was -$14.5M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. PUBM currently screens at market cap $604.7M and trailing P/E 155.8.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. PUBM currently screens at market cap $604.7M and trailing P/E 155.8.
Not investment advice. Open the PODD and PUBM stock pages for the full models.
Not investment advice.